Limoneira【0JV0】銘柄情報 | ADVFN

US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
イギリス
LSE
Limoneira Co (0JV0) 銘柄情報

Limoneira Co (0JV0)

20.47

0.00

(0.00%)

終了 12月18日 1:30AM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

20.47

買値

0.00

売値

0.00

出来高

0.00

0.00 日の範囲 0.00

20.47 52 週間の範囲 20.47

時価総額

前日終値

20.47

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

0.00

発行済株式数

17,979,000

配当利回り

-

PER

53.72

1 株当たり利益 (EPS)

0.5

歳入

182.17M

純利益

8.9M

セクター

Agriculture Production-crops

業界

Agriculture Production-crops

ウェブサイト

www.limoneira.com

本社

Wilmington, Delaware, USA

設立

-

Limoneira Co is listed in the Agriculture Production-crops sector of the ロンドン証券取引所 with ticker 0JV0. The last closing price for Limoneira was 20.47 €. Over the last year, Limoneira shares have traded in a share price range of 20.47 € to 20.47 €.

Limoneira currently has 17,979,000 shares in issue. The market capitalisation of Limoneira is 368.03 € million. Limoneira has a price to earnings ratio (PE ratio) of 53.72.

No news to show yet.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	20.47	20.47	20.47	0	0	DE
4	0	0	20.47	20.47	20.47	0	0	DE
12	0	0	20.47	20.47	20.47	0	0	DE
26	0	0	20.47	20.47	20.47	0	0	DE
52	0	0	20.47	20.47	20.47	0	0	DE
156	0	0	20.47	20.47	20.47	0	20.47	DE
260	0	0	20.47	20.47	20.47	1	20.47	DE

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
TM1Technology Minerals Plc	0.265p (140.91%)	635.73M
HUMHummingbird Resources Plc	2.30p (39.39%)	8.51M
QEDQuadrise Plc	6.00p (29.03%)	28.48M
LPALpa Group Plc	72.00p (26.32%)	63.26k
DARDar Global Plc	US$ 6.00 (22.45%)	16.75k
APIAbrdn Property Income Trust Limited	9.51p (-84.36%)	13.57M
KDNCCadence Minerals Plc	1.65p (-40.00%)	17.87M
BLUBlue Star Capital Plc	0.015p (-25.00%)	18.2M
SYMESupply@me Capital Plc	0.0034p (-22.73%)	1.43B
SCGLSealand Capital Galaxy Limited	1.40p (-22.22%)	6.15M
NTVONativo Resources Plc	0.0021p (-12.50%)	4.78B
SYMESupply@me Capital Plc	0.0034p (-22.73%)	1.43B
TRPTower Resources Plc	0.031p (8.77%)	637.54M
TM1Technology Minerals Plc	0.265p (140.91%)	635.73M
ORCPOracle Power Plc	0.026p (-3.70%)	340.06M

TheDane

TheDane 5分前

Not only did it hold but it’s on the way back up.

OnTrack444

OnTrack444 5分前

Might see a dime after the RS!

If you think a 30B OS OTC stock is going to run from .0011 to .10 you're smoking something pretty whacky!! Find a low OS stock with catalysts in place and it's entirely possible but not this one my friend!!! GLTY

manibiotech

manibiotech 6分前

Interesting for sure but not conclusive which he repeat every day

But there are other things mentioned in that paragraph besides "Neuroscience" ( not Neuro-oncology). And there are other categories of vaccines in development even in neuroscience

FACT-MASTER

FACT-MASTER 7分前

Pivotal Study Design.

Through a meeting with the FDA, the Company obtained feedback on the potential registrational pathway following the Phase 1 ALLOHA trial. Based on this feedback, the Company believes that for a registrational trial: (1) the following proposed patient population i

arizona1

arizona1 8分前

Never trumpers are hilarious and brilliant too.

jimr1717

jimr1717 9分前

“ which now includes 17 issued U.S. patents and 84 pending”

It has taken them from $90,000 to $2 bucks in share price to get 17 of 101 patents.

There will be people that might need a million dollar share price to brake even by then.

This Fake it sham is

NoMoDo

NoMoDo 10分前

If we don't see a dime, I will be shocked.

Slyhunter

Slyhunter 10分前

I did Uber, when it was worth doing. Made, sometimes $300 a day at the b3e3ginning when they first started in my county, It was disastrous to not get out of the car and inspect the backseat to insure it was clean between fares, especially when driving dr8u8nks home at night. I don't see how Tesla is

nfrequent

nfrequent 10分前

Get ready. Phase One complete!!!
https://archive.fast-edgar.com/20241217/AP2Z522CZZ2R52V222JG2WY2CDQEZZ226L62/

XMaster2023

XMaster2023 10分前

Well now kinda sensitive. We can only talk about others tracking the approval one time because it doesn’t meet your short agenda? Funny how an American Society are tracking approval in the UK. They understand the approval will have a big impact on the gene therapy world. Your tacid comments will

Guzzi62

Guzzi62 11分前

I will be holding until approval for sure, but are uncertain on what I will do after.

I want to get out asap, can't stand the management, they are the reason that the pipeline has taken so long due to their own greed.

Furthermore, I really hope for a BO as well.

TRAPPER JIM

TRAPPER JIM 11分前

It's a 2006 F150. Really enjoy having hear again. I'm ready to be done with all the work in the new house. Literally been working everyday on it for two months now. Either working before and after work plus working every weekend on it. Haven't had a day off for two months now. Really getting worn ou

Moonboy1

Moonboy1 11分前

They will pump this when Bitcoin gets down to 103-104 level in my opinion. They will want to steal more money to buy more Bitcoin at these levels. Could go up 5-15% before they rug pull as always. Just watch. Just my opinion.

NoMoDo

NoMoDo 11分前

BTW, FORW was once at .0004. I told friends on PM that I believed the stock was going above .25. People that followed me and would discuss stocks daily. I'd say that they all thought I was full of it. Two told me directly. That stock went over a buck along with HMBL. We will see how things go

OMOLIVES

OMOLIVES 12分前

Just wrong man. All of it wrong:

https://api.mziq.com/mzfilemanager/v2/d/008ff0e9-ebe5-4a1f-81d8-2566deb10aa1/d106aad0-6693-5a04-bd4f-fdcde3c4cddf?origin=1

https://api.mziq.com/mzfilemanager/v2/d/008ff0e9-ebe5-4a1f-81d8-2566deb10aa1/4303be6b-ea00-b3a1-c292-ab3a338d84fd

janice shell

janice shell 13分前

Yes, it was. And fun too.

FACT-MASTER

FACT-MASTER 13分前

TCRX: From the recent 8k filing December 9/24

Solid Tumor Program.

TScan is building and expanding the ImmunoBank of T cell receptors (TCRs) to enable enhanced, multiplex TCR-engineered T cell (TCR-T) therapy, which is designed to address the heterogeneity of solid tumo

manibiotech

manibiotech 13分前

Well he is trying very hard to be .... give him credit for trying

TechandBio

TechandBio 14分前

Elon Musk is wowed by Google’s new quantum chip, which it claims ‘cracks a key challenge’ that’s existed for almost 3 decades.
https://fortune.com/2024/12/09/google-willow-quantum-chip-elon-musk/

$GOOGL

TRAPPER JIM

TRAPPER JIM 14分前

Thank you. Had a super nice warm spring like day today. Up in the mid 60s today.

norisknorewards

norisknorewards 15分前

It specifically calls out neurology, near end of his post.

I found it interesting

MoneyMike1

MoneyMike1 15分前

There was a study recently released by IMCO and AMGN, which triggered many, many articles to be released in the past week or so.

Here's the IMCO page, where you can download the PDF if you wish.

https://imco-org-mx.translate.goog/gas-natural-aliado-de-la-transicion-ene

Slyhunter

Slyhunter 16分前

I hope they're right. I can't sell until January for tax purposes, so I'm stuck at the moment. It's almost doubled in value, since I bought the stock. Getting into scary territory, like when I made 600% profit on Kmart stock. I sold too soon, could've made more, but they went bankrupt again a short

jimr1717

jimr1717 16分前

The question is. Who will you appoint for the board monitor position when you leave in a couple of days?
Someone needs to pick up the slack.

MrMike241

MrMike241 16分前

Hope! Finally, something for the shareholders. Now I regret not averaging down at 75 cents 🙃

Keep up the shareholder friendly communications and actions, Charlie! 🤞

$2,000,000 Share Buyback is a good start and it's much appreciated at this critical PPS

Soc Marseillaise Tunnel ...

DIFF25F27 - 01/2025

DJ US Short Relative Val...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約